000 01515 a2200433 4500
005 20250513191128.0
264 0 _c19991018
008 199910s 0 0 eng d
022 _a0105-2896
024 7 _a10.1111/j.1600-065x.1999.tb01307.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaneja, V
245 0 0 _aHLA class II transgenic mice as models of human diseases.
_h[electronic resource]
260 _bImmunological reviews
_cJun 1999
300 _a67-79 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
650 0 4 _aAmino Acid Sequence
650 0 4 _aAnimals
650 0 4 _aArthritis, Rheumatoid
_xgenetics
650 0 4 _aAutoimmune Diseases
_xgenetics
650 0 4 _aDiabetes Mellitus, Type 1
_xgenetics
650 0 4 _aDisease Models, Animal
650 0 4 _aGenes, MHC Class II
650 0 4 _aHLA-DQ Antigens
_xgenetics
650 0 4 _aHLA-DR Antigens
_xgenetics
650 0 4 _aHumans
650 0 4 _aHypersensitivity
_xgenetics
650 0 4 _aMice
650 0 4 _aMice, Transgenic
650 0 4 _aMultiple Sclerosis
_xgenetics
650 0 4 _aMyasthenia Gravis
_xgenetics
650 0 4 _aPolychondritis, Relapsing
_xgenetics
650 0 4 _aSelection, Genetic
650 0 4 _aThyroiditis, Autoimmune
_xgenetics
650 0 4 _aVaccines
_xgenetics
700 1 _aDavid, C S
773 0 _tImmunological reviews
_gvol. 169
_gp. 67-79
856 4 0 _uhttps://doi.org/10.1111/j.1600-065x.1999.tb01307.x
_zAvailable from publisher's website
999 _c10408201
_d10408201